benign prostatic hyperplasia (bph) . marketing authorization (ma) was obtained in . since the early s, pierre fabre's pharmaceutical business has been a key player in the treatment of benign prostatic hyperplasia (bph). the prescription drug developed back then remains one of the signature products...